MOG and myeloid sarcoma: We found a lower frequency of CSF OB positivity (27%) in MOG-Ab+ ADS patients in comparison to MOG-Ab– patients (70%) as found in a previous larger population (23) showing a frequency of 9.1% of CSF OB positivity in MOG-Ab+ and of 94.6% in MOG-Ab– pediatric MS patients.